Astrana Health, Inc. ASTH revenue by segment, product and geography
In its fiscal year ending 2025-12-31, Astrana Health, Inc. reported revenue across 5 products and services; the largest, Health Care Capitation Revenue, was $2.92B, 91.9% of the filed sum (+57.5% against the prior period in the same filing).
Reported segment mix
figures as filed · share of the filed sum · change vs the prior period in the same filing- Health Care Capitation Revenue$2.92B91.9%+57.5% yoy
- Health Care Patient Service$113M3.5%+80.7% yoy
- Health Care Other$86.2M2.7%0.0% yoy
- Management Service$30.4M1.0%+117.4% yoy
- Product And Service Other$28.3M0.9%+85.8% yoy
Members sum to the consolidated $3.18B for this period.
- Health Care Capitation Revenue$906M93.1%+47.5% yoy
- Health Care Patient Service$23M2.4%+28.5% yoy
- Health Care Other$21.8M2.2%+41.6% yoy
- Management Service$13.2M1.4%+412.7% yoy
- Product And Service Other$8.71M0.9%+79.8% yoy
Change is against the same quarter a year earlier, as reported in the same 10-Q.
Source: SEC DERA Financial Statement and Notes data sets. Dimensional XBRL facts on the business-segment, product/service and geographic axes; the engine keeps the accession of every figure. Descriptive and educational, not advice.
About these figures
Companies tag segment, product and geographic revenue as dimensional XBRL facts in their 10-K and 10-Q filings. The SEC publishes those facts in its DERA Financial Statement and Notes data sets; TrendNalysis ingests each monthly file and serves the facts exactly as filed, keyed to the accession of the filing. Shares are of the filed sum. Where a filer tags more than one breakdown on one axis, the sum exceeds consolidated revenue and no shares are computed; where the members do not add up to the consolidated figure, the residual is stated rather than hidden. Missing is never zero.
Descriptive and educational; not investment advice. Methodology and data lineage.